Fig. 4From: GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatmentSerum cytokine secretion in pCR and non-pCR-patients. Cytokine secretion levels were compared in pCR and non-pCR patients using ANOVA. a Baseline (P1), b After the taxane phase (P3)Back to article page